1001Pharmacies is a technology company.
1001Pharmacies is a technology company.
1001Pharmacies has raised $9.0M across 1 funding round.
1001Pharmacies has raised $9.0M in total across 1 funding round.
1001Pharmacies has raised $9.0M in total across 1 funding round.
1001Pharmacies's investors include Kima Ventures.
1001Pharmacies is a French e-commerce marketplace launched in late 2012 as the first platform for online sales of health and parapharmacy products, connecting around ten partner pharmacies initially to sell items like cosmetics, personal care, and medical products.[1] It serves consumers seeking convenient access to a broad catalog of non-prescription health goods through an efficient online service, solving the problem of limited physical pharmacy availability by enabling digital sales from a growing network that reached 900 pharmacies.[1] The company demonstrated strong growth momentum with €1 million in sales in 2013, €7 million in 2014, and €20 million projected for 2015, fueled by a rapidly expanding market.[1]
Founded in 2012 in Montpellier, France (with operations later noted in Lunel, Occitania), 1001Pharmacies emerged to pioneer online parapharmacy sales amid rising e-commerce adoption in healthcare retail.[1][4] Key team members include Charly Aubert (UX Analyst and Product Owner), Mathieu Fortune (Front/UI Developer), and Cyril Grislain (Investor/Business Angel), though specific founders are not detailed in available records; their backgrounds span UX design, development, and investment.[1] Early traction was rapid: starting with ten partner pharmacies, it hit nearly €1 million in first-year sales, scaling to multimillion-euro revenues by 2014, marking pivotal growth in a nascent French online health market.[1] In 2015, it secured €8 million ($8.9 million) from investors Newfund Capital, CM-CIC Capital Privé, and angels like Xavier Niel, validating its model.[5]
1001Pharmacies rides the e-commerce boom in healthcare retail, particularly the shift to online parapharmacy sales in Europe where regulatory hurdles had previously limited digital access to health products.[1][5] Timing was ideal post-2012, aligning with consumer demand for convenience amid growing internet penetration and marketplace models like Amazon influencing sectors like cosmetics and personal care.[1] Market forces favoring it include France's expanding online health market and partnerships enabling small pharmacies to compete digitally, influencing the ecosystem by democratizing e-commerce for 900+ independents and categorizing within digital health platforms for non-prescription goods.[1][6]
1001Pharmacies is poised to deepen its dominance in French online parapharmacy through network expansion and tech enhancements, potentially targeting cross-border growth as EU e-health regulations evolve. Trends like AI-driven personalization, subscription models for wellness products, and integration with telehealth could accelerate its trajectory, evolving its influence from a pioneer marketplace to a full-stack health e-commerce leader—building on its early revenue surges to capture more of the booming €20M+ annual sales potential.[1][5]
1001Pharmacies has raised $9.0M across 1 funding round. Most recently, it raised $9.0M Series A in July 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2015 | $9.0M Series A | Kima Ventures |